KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $7,575,000 | -11.6% | 2,228,059 | -2.2% | 0.27% | -12.9% |
| Q2 2018 | $8,565,000 | +9.3% | 2,278,007 | +18.9% | 0.31% | +1.6% |
| Q1 2018 | $7,838,000 | -11.8% | 1,916,474 | +0.3% | 0.31% | -12.3% |
| Q4 2017 | $8,889,000 | -21.8% | 1,911,657 | +19.4% | 0.35% | -30.6% |
| Q3 2017 | $11,368,000 | -5.7% | 1,601,172 | -3.9% | 0.50% | -4.0% |
| Q2 2017 | $12,052,000 | +45.9% | 1,666,934 | +24.3% | 0.52% | +30.3% |
| Q1 2017 | $8,258,000 | +8.3% | 1,340,649 | +3.0% | 0.40% | +4.7% |
| Q4 2016 | $7,624,000 | +8.3% | 1,300,993 | -1.9% | 0.38% | +4.3% |
| Q3 2016 | $7,041,000 | +16.5% | 1,325,917 | +45.3% | 0.37% | +5.7% |
| Q2 2016 | $6,043,000 | +43.6% | 912,830 | +1.3% | 0.35% | +43.2% |
| Q1 2016 | $4,208,000 | -3.8% | 901,063 | +4.0% | 0.24% | -2.8% |
| Q4 2015 | $4,376,000 | +140.8% | 866,629 | +67.9% | 0.25% | +111.9% |
| Q3 2015 | $1,817,000 | -59.3% | 516,289 | +15.3% | 0.12% | -54.3% |
| Q2 2015 | $4,468,000 | -28.5% | 447,711 | -8.8% | 0.26% | -28.7% |
| Q1 2015 | $6,250,000 | +148.3% | 490,987 | +176.0% | 0.36% | +136.6% |
| Q4 2014 | $2,517,000 | +54.0% | 177,877 | +49.6% | 0.15% | +34.2% |
| Q3 2014 | $1,634,000 | – | 118,869 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |